Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
GPR164 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 1 publication
Supplier: Novus Biologicals NBP213701
Description
GPR164 Polyclonal specifically detects GPR164 in Human, Mouse samples. It is validated for Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
GPR164 | |
Polyclonal | |
Immunohistochemistry 1:20 - 1:50, Immunocytochemistry/Immunofluorescence 1 - 4 ug/ml, Immunohistochemistry-Paraffin 1:20 - 1:50 | |
D-GPCR, Dresden-G-protein-coupled receptor, FLJ13581, GPR136, GPR164, G-protein coupled receptor 164, MGC24137, olfactory receptor 51E1, Olfactory receptor 52A3, olfactory receptor OR11-15, olfactory receptor, family 51, subfamily E, member 1, olfactory receptor, family 51, subfamily E, member 1 pseudogene, olfactory receptor, family 52, subfamily A, member 3 pseudogene, OR51E1P, OR52A3P, POGR, prostate overexpressed G protein-coupled receptor, Prostate-overexpressed G protein-coupled receptor, Prostate-specific G protein-coupled receptor 2, PSGR2 | |
Rabbit | |
Affinity Purified | |
RUO | |
Primary | |
Specificity of human GPR164 antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
Unconjugated | |
PBS (pH 7.2) and 40% Glycerol with 0.02% Sodium Azide | |
OR51E1 | |
This antibody was developed against Recombinant Protein corresponding to amino acids: VKTKEIRQRILRLFHVATHASEP | |
0.1 mL | |
GPCR | |
143503 | |
Human, Mouse | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction